Home CTLT
52.25
  Price0.04%   +0.02
 
loading

Catalent, Inc. (CTLT) Latest News

Dec-03-22 08:12AM Wall Street Breakfast: What Moved MarketsSeeking Alpha
Dec-02-22 11:31AM Why Is United Therapeutics (UTHR) Up 3.8% Since Last Earnings Report?Zacks Investment Research
Dec-01-22 06:20AM Is Invesco Dynamic Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?Zacks Investment Research
Nov-16-22 09:02AM CarParts and Catalent have been highlighted as Zacks Bull and Bear of the DayZacks Investment Research
07:13AM Bear Of The Day: Catalent (CTLT)Zacks Investment Research
Nov-07-22 09:25AM Benzinga's Top Ratings Upgrades, Downgrades For November 7, 2022Benzinga
Nov-05-22 08:21AM Wall Street Breakfast: What Moved MarketsSeeking Alpha
Nov-04-22 06:19AM Why Shares of Catalent Fell 36% This WeekThe Motley Fool
Nov-02-22 04:18AM Where Catalent Stands With AnalystsBenzinga
10:06AM Benzinga's Top Ratings Upgrades, Downgrades For November 2, 2022Benzinga
Nov-02-22 09:28AM Analyst Ratings for CatalentBenzinga
05:07AM Why Harsco Shares Surged Over 22%; Here Are 80 Biggest Movers From YesterdayBenzinga
Nov-01-22 05:52AM Why Catalent Stock Plummeted by Nearly 25% TodayThe Motley Fool
01:11AM Catalent (CTLT) Q1 Earnings Lag Estimates, FY23 View CutZacks Investment Research
Nov-01-22 12:38PM Why Abiomed Shares Are Trading Higher By Over 50%? Here Are 60 Stocks Moving In Tuesday's Mid-Day SessionBenzinga
12:01PM Dow Drops Over 200 Points; Crude Oil Rises SharplyBenzinga
Nov-01-22 11:36AM Goodyear Tire, Catalent, Zebra Technologies And Some Other Big Stocks Moving Lower On TuesdayBenzinga
10:21AM US Stocks Trade Lower Ahead Of Fed Meeting; Pfizer Earnings Top ViewsBenzinga
Nov-01-22 08:25AM Catalent (CTLT) Q1 Earnings and Revenues Miss EstimatesZacks Investment Research
Oct-31-22 11:35AM MedTech Stocks Due to Report Earnings on Nov 1: MCK, CTLT & MoreZacks Investment Research
Oct-27-22 06:20AM Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?Zacks Investment Research
Oct-26-22 10:14AM Catalent (CTLT) to Report Q1 Earnings: What's in the Cards?Zacks Investment Research
10:02AM United Therapeutics (UTHR) Earnings Expected to Grow: Should You Buy?Zacks Investment Research
Oct-25-22 10:01AM Analysts Estimate Catalent (CTLT) to Report a Decline in Earnings: What to Look Out forZacks Investment Research
Oct-14-22 06:41AM New Strong Sell Stocks for October 14thZacks Investment Research
Oct-06-22 03:27AM 7 Analysts Have This to Say About CatalentBenzinga
Oct-04-22 11:40AM JAZZ vs. CTLT: Which Stock Is the Better Value Option?Zacks Investment Research
Sep-28-22 11:30AM Why Is Catalent (CTLT) Down 18.5% Since Last Earnings Report?Zacks Investment Research
Sep-27-22 04:58AM Why Moderna Stock Crushed the Market TodayThe Motley Fool
Sep-26-22 06:20AM Is Invesco Dynamic Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?Zacks Investment Research
Sep-24-22 08:16AM These 20 stocks in the S&P skidded as much as 21.5% during another brutal week for the marketMarketWatch
Sep-23-22 05:09AM These 20 stocks in the S&P skidded as much as 21.5% during another brutal week for the marketMarketWatch
Sep-21-22 11:42AM Moderna expects the shortage of its updated COVID-19 booster to soon be resolvedMarketWatch
Sep-19-22 10:40AM 3 Reasons to Hold Catalent (CTLT) Stock in Your PortfolioZacks Investment Research
Sep-03-22 07:58AM Wall Street Breakfast: What Moved MarketsSeeking Alpha
Aug-30-22 03:00AM Despite Price Cut, RBC Capital Is Bullish On Catalent's Long Term TargetsBenzinga
01:01AM Expert Ratings for CatalentBenzinga
Aug-30-22 11:20AM Catalent (CTLT) Stock Down Despite Q4 Beat: Will it Recover?Zacks Investment Research
10:14AM Where Catalent Stands With AnalystsBenzinga
Aug-30-22 09:33AM Company News for Aug 30, 2022Zacks Investment Research
08:36AM Catalent Faces Several Price Target Cuts By Analysts After Q4 ResultsBenzinga
Aug-30-22 07:40AM HC Wainwright Boosts Price Target On This Stock By 167%, Plus B of A Securities Predicts $40 For This Online Travel StockBenzinga
07:21AM Catalent To $115? Here Are 5 Other Price Target Changes For TuesdayBenzinga
Aug-30-22 05:23AM Why Bed Bath & Beyond Jumped Around 25%; Here Are 68 Biggest Movers From YesterdayBenzinga
04:12AM Catalent, Tellurian And Other Big Losers From MondayBenzinga
Aug-29-22 06:00AM Catalent (CTLT) Q4 2022 Earnings Call TranscriptThe Motley Fool
12:49PM Why Chimerix Is Trading Higher By Over 19%, Here Are 53 Stocks Moving In Monday's Mid-Day SessionBenzinga
Aug-29-22 11:33AM Catalent (CTLT) Q4 Earnings Beat Estimates, Revenues LagZacks Investment Research
08:15AM Catalent (CTLT) Q4 Earnings Surpass EstimatesZacks Investment Research
Aug-29-22 07:31AM US Futures Paint Gloomy Outlook For Fresh Trading Week As Data-Dependence Introduces Caution Ahead Of Key Main Street Readings, Fed SpeechesBenzinga
Catalent, Inc. provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products worldwide. It operates through four segments: Softgel Technologies, Biologics and Specialty Drug Delivery, Oral Drug Delivery, and Clinical Supply Services. The Softgel Technologies segment formulates, develops, and manufactures prescription and consumer soft capsules for use in a range of customer products, such as prescription drugs, over-the-counter medications, dietary supplements, unit-dose cosmetics, and animal health medicinal preparations. The Biologics and Specialty Drug Delivery segment formulates, develops, and manufactures small molecule and biologic drug products in prefilled syringes, vials and cartridges, blow-fill-seal unit doses, and injectable formats; develops biologic cell lines; manufactures biologic drug substances; and offers bioanalytical development and testing services. The Oral Drug Delivery segment formulates, develops, and manufactures oral dosage forms using proprietary and conventional drug delivery technologies, such as Zydis, OptiDose CR, OptiPact, OptiForm API and Solution Suite, Pharmatek SD Spray Drying, OptiMelt hot melt extrusion, Micron particle size reduction, and FlexDose; and provides stick pack formulation and filling, and analytical development and testing services. The Clinical Supply Services segment offers Manufacturing, packaging, labeling, storage, distribution, and inventory management for drugs and biologics clinical trials; FastChain demand-led clinical supply services; clinical e-solutions and informatics; and comparator sourcing services. The company serves pharmaceutical, biotechnology, and consumer health companies; and companies in other healthcare market segments, such as animal health and medical devices, as well as in cosmetics industries. Catalent, Inc. was founded in 2007 and is headquartered in Somerset, New Jersey.
Cap:    |  Volume (24h):